Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial registered on ANZCTR
Registration number
ACTRN12610000991011
Ethics application status
Approved
Date submitted
15/11/2010
Date registered
16/11/2010
Date last updated
12/11/2013
Type of registration
Prospectively registered
Titles & IDs
Public title
Dietary supplements and ocular (eye) comfort
Query!
Scientific title
A randomised placebo-controlled double-masked study to investigate the effects of dietary supplementation with a combination of omega oils on ocular comfort including symptoms of dry eye
Query!
Secondary ID [1]
253081
0
SOVS2010_BK001
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Ocular comfort including symptoms of dry eye
258646
0
Query!
Condition category
Condition code
Eye
258784
258784
0
0
Query!
Normal eye development and function
Query!
Alternative and Complementary Medicine
258799
258799
0
0
Query!
Other alternative and complementary medicine
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Dietary supplementation with a combination of omega oils. Dosage of EPA (~550mg), DHA (~120mg) and a combination of liolenic acids per 3 capsules per day for 3 months
Query!
Intervention code [1]
257601
0
Other interventions
Query!
Intervention code [2]
257618
0
Prevention
Query!
Comparator / control treatment
Parrafin oil containing capsules. Dosage of three capsules per day for 3 months
Query!
Control group
Placebo
Query!
Outcomes
Primary outcome [1]
259651
0
Subjective ocular comfort assessed using validated questionnaires (OCI, OSDI, SESOD, numerical rating scales, WHS, DEQ)
Query!
Assessment method [1]
259651
0
Query!
Timepoint [1]
259651
0
Baseline, 1 month, 3-month
Query!
Secondary outcome [1]
266318
0
Tear Film Stability, volume and composition assessed using NIBUT, osmometry, phenol red thread test
Query!
Assessment method [1]
266318
0
Query!
Timepoint [1]
266318
0
Baseline, 3-month
Query!
Secondary outcome [2]
266319
0
Lipid layer thickness and meibum composition using tearscope, validated grading scales and spectrum analysis
Query!
Assessment method [2]
266319
0
Query!
Timepoint [2]
266319
0
Baseline, 3-month
Query!
Secondary outcome [3]
266320
0
Cell and nerve morphology using impression cytology and confocal microscopy
Query!
Assessment method [3]
266320
0
Query!
Timepoint [3]
266320
0
Baseline, 3-month
Query!
Eligibility
Key inclusion criteria
Willing to comply with the dosage and study visit schedule
Contact lens wearers and non contact lens wearers
At least 18 years old
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
Yes
Query!
Key exclusion criteria
Current consumption of omega oil dietary supplements
Moderate or severe dry eye disease
Systematic disease that would preclude participants from safely ingesting dietary supplementation with omega oils
No S3 or above ocular medications
No use of any anticoagulants or blood thinning medications
Query!
Study design
Purpose of the study
Prevention
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Allocation to treatment is conducted following enrolment using numbered containers
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Randomisation will be stratified by contact lens wear. The manufacturer will code, bottle and label study supplies.
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Efficacy
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Date of first participant enrolment
Anticipated
15/11/2010
Query!
Actual
4/03/2011
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
6/03/2012
Query!
Date of last data collection
Anticipated
Query!
Actual
Query!
Sample size
Target
80
Query!
Accrual to date
Query!
Final
Query!
Recruitment in Australia
Recruitment state(s)
Query!
Recruitment postcode(s) [1]
3434
0
2031
Query!
Recruitment postcode(s) [2]
3435
0
2033
Query!
Recruitment postcode(s) [3]
3436
0
2032
Query!
Recruitment postcode(s) [4]
3437
0
2052
Query!
Recruitment postcode(s) [5]
3438
0
2035
Query!
Recruitment postcode(s) [6]
3439
0
2036
Query!
Recruitment postcode(s) [7]
3440
0
2034
Query!
Funding & Sponsors
Funding source category [1]
258057
0
Commercial sector/Industry
Query!
Name [1]
258057
0
Blackmores Limited
Query!
Address [1]
258057
0
20 Jubilee Avenue
Warriewood NSW 2021
Query!
Country [1]
258057
0
Australia
Query!
Funding source category [2]
258058
0
University
Query!
Name [2]
258058
0
University of New South Wales
Query!
Address [2]
258058
0
School of Optometry and Vision Science
The Unviersity of New South Wales
UNSW Sydney NSW 2052
Query!
Country [2]
258058
0
Australia
Query!
Primary sponsor type
Commercial sector/Industry
Query!
Name
Blackmores Limited
Query!
Address
20 Jubilee Avenue
Warriewood NSW 2021
Query!
Country
Australia
Query!
Secondary sponsor category [1]
257250
0
University
Query!
Name [1]
257250
0
University of New South Wales
Query!
Address [1]
257250
0
School of Optometry and Vision Science
The Unviersity of New South Wales
UNSW Sydney NSW 2052
Query!
Country [1]
257250
0
Australia
Query!
Ethics approval
Ethics application status
Approved
Query!
Ethics committee name [1]
260055
0
Human Research Ethics Committee
Query!
Ethics committee address [1]
260055
0
Grant Management Office The University of New South Wales UNSW Sydney NSW 2052
Query!
Ethics committee country [1]
260055
0
Australia
Query!
Date submitted for ethics approval [1]
260055
0
06/04/2010
Query!
Approval date [1]
260055
0
25/06/2010
Query!
Ethics approval number [1]
260055
0
10110
Query!
Summary
Brief summary
This study aims to test whether omega oils taken as capsules can help in improving ocular comfort.
Query!
Trial website
http://www.optom.unsw.edu.au/news/2010/Researchrecruit.html
Query!
Trial related presentations / publications
1. Jalbert I, Gokhale M, Golebiowski B, Madigan M, Badarudin N, Garg M, Stapleton F. Effect of a combination omega dietary nutraceutical on symptoms of ocular discomfort, clinical indicators and biomarkers of ocular surface health. Optom Vis Sci 2013; 90: E-abstract 130891. 2. Golebiowski B, Hampel U, Badarudin N, Gokhale M, Jalbert I, Madigan M, Stapleton F. Is there a relationship between ocular discomfort and circulating plasma levels of sex hormones? Invest Ophthalmol Vis Sci 2013; 54: ARVO abstract 969. 3. Golebiowski B, Hampel U, Badarudin N, Gokhale M, Madigan M, Jalbert I, Stapleton F. Higher plasma levels of oestradiol are associated with increased ocular discomfort in women. 7th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance, Taormina, Italy, September 2013. 4. Hampel U, Golebiowski B, Badarudin N, Jalbert I, Madigan MC, Stapleton F. Is there a relationship between ocular discomfort and circulating 3a-diol-G and DHEA-S serum levels in post-menopausal women? Stapleton F. Higher plasma levels of oestradiol are associated with increased ocular discomfort in women. 7th International Conference on the Tear Film & Ocular Surface: Basic Science and Clinical Relevance, Taormina, Italy, September 2013.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
31910
0
Dr Isabelle Jalbert
Query!
Address
31910
0
School of Optometry and Vision Science
The University of New South Wales
Sydney NSW 2052
Query!
Country
31910
0
Australia
Query!
Phone
31910
0
+61-2-9385-9816
Query!
Fax
31910
0
Query!
Email
31910
0
[email protected]
Query!
Contact person for public queries
Name
15157
0
Isabelle Jalbert
Query!
Address
15157
0
School of Optometry and Vision Science
The University of New South Wales
Sydney NSW 2052
Query!
Country
15157
0
Australia
Query!
Phone
15157
0
61-2-9385-9816
Query!
Fax
15157
0
61-2-9313-6243
Query!
Email
15157
0
[email protected]
Query!
Contact person for scientific queries
Name
6085
0
Isabelle Jalbert
Query!
Address
6085
0
School of Optometry and Vision Science
The University of New South Wales
Sydney NSW 2052
Query!
Country
6085
0
Australia
Query!
Phone
6085
0
61-2-9385-9816
Query!
Fax
6085
0
61-2-9313-6243
Query!
Email
6085
0
[email protected]
Query!
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Documents added manually
No documents have been uploaded by study researchers.
Documents added automatically
Source
Title
Year of Publication
DOI
Embase
Omega-3 and omega-6 polyunsaturated fatty acids for dry eye disease.
2019
https://dx.doi.org/10.1002/14651858.CD011016.pub2
N.B. These documents automatically identified may not have been verified by the study sponsor.
Download to PDF